Randomized Controlled Trial
doi: 10.1016/j.radonc.2009.05.005.
Epub 2009 Jun 11.
Radiotherapy compliance is maintained with hypofractionation and concurrent cetuximab in locally advanced head and neck cancer
- PMID: 19524312
- DOI: 10.1016/j.radonc.2009.05.005
Item in Clipboard
Randomized Controlled Trial
Radiotherapy compliance is maintained with hypofractionation and concurrent cetuximab in locally advanced head and neck cancer
Radiother Oncol.
2009 Dec.
No abstract available
Comment on
-
Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer.Radiother Oncol. 2009 Feb;90(2):172-6. doi: 10.1016/j.radonc.2008.09.018. Epub 2008 Oct 29. Radiother Oncol. 2009. PMID: 18976827
Similar articles
-
Hypofractionated radiotherapy plus cetuximab in locally advanced head and neck cancer.Clin Oncol (R Coll Radiol). 2008 Nov;20(9):717. doi: 10.1016/j.clon.2008.07.003. Epub 2008 Aug 30. Clin Oncol (R Coll Radiol). 2008. PMID: 18757187 No abstract available.
-
Cetuximab plus radiotherapy for head and neck cancer.N Engl J Med. 2006 May 18;354(20):2187; author reply 2187. N Engl J Med. 2006. PMID: 16710907 No abstract available.
-
Cetuximab plus radiotherapy for head and neck cancer.N Engl J Med. 2006 May 18;354(20):2187; author reply 2187. N Engl J Med. 2006. PMID: 16710908 No abstract available.
-
Cetuximab combined with radiotherapy: an alternative to chemoradiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck?Eur J Cancer. 2007 Jan;43(1):35-45. doi: 10.1016/j.ejca.2006.08.035. Epub 2006 Nov 13. Eur J Cancer. 2007. PMID: 17098420 Review.
-
Cetuximab in the management of locoregionally advanced head and neck cancer: expanding the treatment options?Eur J Cancer. 2010 Jul;46(11):1979-89. doi: 10.1016/j.ejca.2010.05.015. Epub 2010 Jun 17. Eur J Cancer. 2010. PMID: 20561781 Review.
Cited by
-
Cetuximab: its unique place in head and neck cancer treatment.Biologics. 2013;7:77-90. doi: 10.2147/BTT.S43628. Epub 2013 Apr 15. Biologics. 2013. PMID: 23723688 Free PMC article.
-
Hypofractionated chemoradiation for head and cancer: Data from the PET NECK trial.Oral Oncol. 2021 Feb;113:105112. doi: 10.1016/j.oraloncology.2020.105112. Epub 2020 Dec 13. Oral Oncol. 2021. PMID: 33321287 Free PMC article.
-
Hypofractionated radiotherapy combined with cetuximab in vulnerable elderly patients with locally advanced head and neck squamous cell carcinoma.Med Oncol. 2019 Jun 12;36(8):68. doi: 10.1007/s12032-019-1292-y. Med Oncol. 2019. PMID: 31190132 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
